Clinical Trial

Effects of Transcutaneous Electrical Phrenic Nerve Stimulation and Transcutaneous Electrical Diaphragmatic Stimulation

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2025 (before its estimated December 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
Transcutaneous electrical phrenic nerve stimulation (TEPNS) and transcutaneous electrical diaphragm stimulation (TEDS) are modalities that use surface electrodes placed on the patients' skin to generate action potentials and contractions of the muscle fibers of the diaphragm. The primary objective will be to evaluate the efficacy of TEPNS and TEDS in healthy adult individuals. Secondary objectives will be to assess the feasibility, safety, and level of discomfort reported by the individual resulting from the application of TEPNS and TEDS.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-03-25; most recent amendment 2025-04-22.
Status change: Not Yet Recruiting → Recruiting 2024-04-16
Trial Details
NCT Number NCT06339632
Lead Sponsor Hospital Sirio-Libanes
Collaborators: Hospital Israelita Albert Einstein
Conditions Diaphragm
Enrollment 12 participants
Start Date 2024-04-01
Primary Completion 2025-12-28 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-24